Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated May 13, 2016 (10 years ago)

Hyoscyamine Sulfate Sublingual Tablets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Chemical Contamination: Bottles may contain broken dessicants

Cause type: Chemical / undeclared

A chemical that should not be there - benzene, methanol, lead - or an undeclared prescription drug hidden in a supplement. The label gives no warning: you may be taking a toxic solvent, a heavy metal, or a drug such as sildenafil that interacts with your other medicines. All chemical / undeclared recalls.

What was recalled

Hyoscyamine Sulfate Sublingual Tablets, 0.125 mg, packaged in 100-count bottles, Rx only, Manufactured for: Virtus Pharmaceuticals OPCO II, LLC. Nashville, TN 37217. NDC 76439-0309-10

Affected NDC 76439-0309-10

Compare with the code on your package — it is the most precise check available.

Drug: Hyoscyamine

Recalling firm
Virtus Pharmaceuticals, Llc
NDC code
76439-0309-10
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1044-2016 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Hyoscyamine recalls

See all
Class II · Moderate risk

Levsin injection

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Terminated cGMP deviation Viatris Inc NDC 0037-9001-05 D-0866-2023
Class II · Moderate risk

Vilamit Mb

cGMP deviations

Terminated cGMP deviation Vilvet Pharmaceuticals Inc. NDC 71186-002-35 D-1487-2020

Other recalls by Virtus Pharmaceuticals, Llc

All 2016 recalls
Class III · Low risk

Virt-Nate Prenatal/Postnatal

Tablets/Capsules Imprinted with Wrong ID; product debossed with an incorrect punch. Bottles could contain tablets debossed with V259 (debossing for PreTab) instead of the correct punch, V264 (debossing for Virt-Nate).

Terminated Labeling / mix-up Virtus Pharmaceuticals, Llc D-0775-2016